Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) currently has a daily average trading volume of 325.56K but it saw 1301508 shares traded in last market. With a market cap of 7.66B USD, the company’s current market price of $344.97 came rising about 10.87 while comparing to the previous closing price of $311.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $377.46 and as low as $200.63. In the recent trading on the day, stock has struck highest price mark of $327.15 while lowest mark touched by it was $357.91.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the B. Riley Securities which upgraded the stock as “Buy” in its note to investors issued on February 28, 2025, recommending a price target of between $236 and $422 for it.
Over the week, MDGL’s stock price is moving 11.79% up while it is 16.71% when we observe its performance for the past one month. Year-to-date it is 20.68% up and over the past year, the stock is showing an upside performance of 11.80%.
Currently, Madrigal Pharmaceuticals Inc’s total number of outstanding shares is 22.19M. Company’s return on investment (ROI) stands at -47.21% and return on equity (ROE) at -50.16%. It has a 430.79 of forward P/E ratio. Stock’s beta reads -1.02. Stock has a price to book (P/B) ratio of 10.77 while price to sale or P/S ratio amounts to 24.13. Its return on asset (ROA) is -37.67% on average.
